Structure-Related Mode-of-Action Differences of Anticancer Organoruthenium Complexes with β-Diketonates-Reference-Cited by-同舟云学术

Structure-Related Mode-of-Action Differences of Anticancer Organoruthenium Complexes with β-Diketonates

Published:2015-04-17 Issue:9 Volume:58 Page:3984-3996
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Seršen Sara¹,Kljun Jakob¹,Kryeziu Kushtrim²,Panchuk Rostyslav³,Alte Beatrix²,Körner Wilfried⁴,Heffeter Petra²,Berger Walter²,Turel Iztok¹

Affiliation:

1. Faculty of Chemistry and Chemical Technology, University of Ljubljana, Večna pot 113, SI-1000 Ljubljana, Slovenia

2. Department of Medicine I, Institute of Cancer Research and Comprehensive Cancer Center, Medical University Vienna, Borschkegasse 8a, A-1090 Vienna, Austria

3. Institute of Cell Biology, National Academy of Sciences of Ukraine, Lviv, 79005, Ukraine

4. Department of Environmental Geosciences, University of Vienna, 1090, Vienna, Austria

Funder

European Cooperation in Science and Technology

Javna Agencija za Raziskovalno Dejavnost RS

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5b00288

Reference55 articles.

1. Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode

2. Platinum Compounds: a New Class of Potent Antitumour Agents

3. Ruthenium-based chemotherapeutics: are they ready for prime time?

4. Exploration of the medical periodic table: towards new targets

5. Ruthenium complexes can target determinants of tumour malignancy

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metallocompounds as anticancer agents against osteosarcoma;Drug Discovery Today;2024-09

2. 2-Aryl-1H-imidazo[4,5-f][1,10]phenanthroline-Based Binuclear Ru(II)/Ir(III)/Re(I) Complexes as Mitochondria Targeting Cancer Stem Cell Therapeutic Agents;Journal of Medicinal Chemistry;2024-05-30

3. Synthesis and Investigations of the Antitumor Effects of First-Row Transition Metal(II) Complexes Supported by Two Fluorinated and Non-Fluorinated β-Diketonates;International Journal of Molecular Sciences;2024-02-07

4. Organometallic Ru(ii), Rh(iii) and Re(i) complexes of sterane-based bidentate ligands: synthesis, solution speciation, interaction with biomolecules and anticancer activity;Dalton Transactions;2024

5. An overview of advancement of organoruthenium(II) complexes as prospective anticancer agents;Coordination Chemistry Reviews;2023-07